Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2016-05-19 02:30:25 UTC |
---|
Update Date | 2016-11-09 01:13:40 UTC |
---|
Accession Number | CHEM007801 |
---|
Identification |
---|
Common Name | VALENCENE |
---|
Class | Small Molecule |
---|
Description | Valencene is found in citrus. Valencene is a constituent of orange oil |
---|
Contaminant Sources | - EAFUS Chemicals
- FooDB Chemicals
- ToxCast & Tox21 Chemicals
|
---|
Contaminant Type | Not Available |
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
1-(4-(1-Pyrrolidinyl)-2-butynyl)-2-pyrrolidinone | HMDB | 1-(4-(Pyrrolidin-1-yl)but-2-ynyl)pyrrolidin-2-one | HMDB | 1-[4-(1-Pyrrolidinyl)-2-butynyl]-2-pyrrolidinone | HMDB | 2'-Oxopyrrolidino-1-pyrrolidino-4-butyne | HMDB | 4beta H,5alpha -Eremophila-1(10),11-diene | HMDB | oxo-Tremorine | HMDB | Oxotremorin | HMDB | Oxotremorine | HMDB | Oxotremorine sesquifumarate salt | HMDB | Oxytremorine | HMDB | Valencene 85 | HMDB |
|
---|
Chemical Formula | C15H24 |
---|
Average Molecular Mass | 204.351 g/mol |
---|
Monoisotopic Mass | 204.188 g/mol |
---|
CAS Registry Number | 4630-07-3 |
---|
IUPAC Name | 4a,5-dimethyl-3-(prop-1-en-2-yl)-1,2,3,4,4a,5,6,7-octahydronaphthalene |
---|
Traditional Name | valencene |
---|
SMILES | CC1CCC=C2CCC(CC12C)C(C)=C |
---|
InChI Identifier | InChI=1S/C15H24/c1-11(2)13-8-9-14-7-5-6-12(3)15(14,4)10-13/h7,12-13H,1,5-6,8-10H2,2-4H3 |
---|
InChI Key | QEBNYNLSCGVZOH-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as eremophilane, 8,9-secoeremophilane and furoeremophilane sesquiterpenoids. These are sesquiterpenoids with a structure based either on the eremophilane skeleton, its 8,9-seco derivative, or the furoeremophilane skeleton. Eremophilanes have been shown to be derived from eudesmanes by migration of the methyl group at C-10 to C-5. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Prenol lipids |
---|
Sub Class | Sesquiterpenoids |
---|
Direct Parent | Eremophilane, 8,9-secoeremophilane and furoeremophilane sesquiterpenoids |
---|
Alternative Parents | |
---|
Substituents | - Eremophilane sesquiterpenoid
- Branched unsaturated hydrocarbon
- Polycyclic hydrocarbon
- Cyclic olefin
- Unsaturated aliphatic hydrocarbon
- Unsaturated hydrocarbon
- Olefin
- Hydrocarbon
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Not Available |
---|
Cellular Locations | Not Available |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Appearance | Not Available |
---|
Experimental Properties | Property | Value |
---|
Melting Point | Not Available | Boiling Point | Not Available | Solubility | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | View |
---|
GC-MS | GC-MS Spectrum - GC-EI-Q (Non-derivatized) | splash10-06r6-6900000000-6056307d54773f6a82a7 | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-000i-1900000000-924c0ed0f560e2343f55 | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0a4i-1490000000-64b1f2c7f108e8d251ee | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0cdr-3920000000-6ec0f8bff5e08c3188eb | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-000i-6900000000-de9b8430cbefd1ff8a23 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0udi-0090000000-dceadc1eb356d16afae6 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0udi-0190000000-2e9a22282b05ad914329 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-000i-1910000000-25622133ba47e98f5e5d | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0bt9-0970000000-3dce51d91747df18039b | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0a4i-6920000000-7d73224ac3ffa81a2d3c | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0006-9200000000-2cd94e921e3ed07cd790 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0udi-0090000000-7ccf03fa1149a1e9f55f | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0udi-0090000000-7ccf03fa1149a1e9f55f | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0udi-0290000000-6c318cb263f435b16ddb | Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Not Available |
---|
Mechanism of Toxicity | Not Available |
---|
Metabolism | Not Available |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | Not Available |
---|
Uses/Sources | Not Available |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Not Available |
---|
Symptoms | Not Available |
---|
Treatment | Not Available |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
HMDB ID | HMDB0035688 |
---|
FooDB ID | FDB014408 |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | C00034741 |
---|
BiGG ID | Not Available |
---|
BioCyc ID | Not Available |
---|
METLIN ID | Not Available |
---|
PDB ID | Not Available |
---|
Wikipedia Link | Valencene |
---|
Chemspider ID | 254202 |
---|
ChEBI ID | Not Available |
---|
PubChem Compound ID | 288227 |
---|
Kegg Compound ID | C17277 |
---|
YMDB ID | Not Available |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Not Available |
---|
General References | 1. Miwa H, Nishi K, Fuwa T, Mizuno Y: Differential expression of c-fos following administration of two tremorgenic agents: harmaline and oxotremorine. Neuroreport. 2000 Aug 3;11(11):2385-90. | 2. Kuroiwa M, Hamada M, Hieda E, Shuto T, Sotogaku N, Flajolet M, Snyder GL, Hendrick JP, Fienberg A, Nishi A: Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons. Neuropharmacology. 2012 Dec;63(7):1248-57. doi: 10.1016/j.neuropharm.2012.07.046. Epub 2012 Aug 7. | 3. Westermann KH, Oelszner W, Funk KF, Staib AH: Effects of oxotremorine after nigrostriatal lesions in rats. Pol J Pharmacol Pharm. 1975 Jul-Aug;27(4):413-7. | 4. Pavesi E, Gooch A, Lee E, Fletcher ML: Cholinergic modulation during acquisition of olfactory fear conditioning alters learning and stimulus generalization in mice. Learn Mem. 2012 Dec 14;20(1):6-10. doi: 10.1101/lm.028324.112. | 5. Palomares-Rius JE, Jones JT, Cock PJ, Castillo P, Blok VC: Activation of hatching in diapaused and quiescent Globodera pallida. Parasitology. 2013 Apr;140(4):445-54. doi: 10.1017/S0031182012001874. Epub 2012 Dec 20. | 6. Gholami M, Saboory E, Zare S, Roshan-Milani S, Hajizadeh-Moghaddam A: The effect of dorsal hippocampal administration of nicotinic and muscarinic cholinergic ligands on pentylenetetrazol-induced generalized seizures in rats. Epilepsy Behav. 2012 Oct;25(2):244-9. doi: 10.1016/j.yebeh.2012.07.004. Epub 2012 Oct 2. | 7. Daigle TL, Caron MG: Elimination of GRK2 from cholinergic neurons reduces behavioral sensitivity to muscarinic receptor activation. J Neurosci. 2012 Aug 15;32(33):11461-6. doi: 10.1523/JNEUROSCI.2234-12.2012. | 8. Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. | 9. Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. | 10. Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. | 11. Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. | 12. Yannai, Shmuel. (2004) Dictionary of food compounds with CD-ROM: Additives, flavors, and ingredients. Boca Raton: Chapman & Hall/CRC. | 13. The lipid handbook with CD-ROM |
|
---|